United states securities and exchange commission

Restricted Marketable Securities
The Company considers marketable securities to be restricted when withdrawal or general use is legally restricted. The 
Company reports restricted marketable securities as current or non-current marketable securities in the Consolidated Balance 
Sheets based on the classification of the underlying securities.
Property, Plant and Equipment
Depreciation on property, plant and equipment is recognized on a straight-line basis over the estimated useful lives of the assets, 
which for buildings is the shorter of 40 years or the remaining life of the building; between one and five years for machinery and 
equipment, including manufacturing equipment; and the shorter of the lease term or useful life for leasehold improvements. 
Capitalized costs related to internal-use software are amortized on a straight-line basis over the estimated useful lives of the 
assets, which range from five to seven years. Depreciation and amortization expense on property, plant and equipment was $8.7 
billion, $9.5 billion and $9.7 billion during 2022, 2021 and 2020, respectively.
Derivative Instruments and Hedging
All derivative instruments are recorded in the Consolidated Balance Sheets at fair value. The accounting treatment for derivative 
gains and losses is based on intended use and hedge designation.
Gains and losses arising from amounts that are included in the assessment of cash flow hedge effectiveness are initially deferred 
in accumulated other comprehensive income/(loss) (“AOCI”) and subsequently reclassified into earnings when the hedged 
transaction affects earnings, and in the same line item in the Consolidated Statements of Operations. For options designated as 
cash flow hedges, the Company excludes time value from the assessment of hedge effectiveness and recognizes it on a 
straight-line basis over the life of the hedge in the Consolidated Statements of Operations line item to which the hedge relates. 
Changes in the fair value of amounts excluded from the assessment of hedge effectiveness are recognized in other 
comprehensive income/(loss) (“OCI”).
Gains and losses arising from amounts that are included in the assessment of fair value hedge effectiveness are recognized in 
the Consolidated Statements of Operations line item to which the hedge relates along with offsetting losses and gains related to 
the change in value of the hedged item. For foreign exchange forward contracts designated as fair value hedges, the Company 
excludes the forward carry component from the assessment of hedge effectiveness and recognizes it in other income/(expense), 
net (“OI&E”) on a straight-line basis over the life of the hedge. Changes in the fair value of amounts excluded from the 
assessment of hedge effectiveness are recognized in OCI.
Gains and losses arising from changes in the fair values of derivative instruments that are not designated as accounting hedges 
are recognized in the Consolidated Statements of Operations line items to which the derivative instruments relate.
The Company presents derivative assets and liabilities at their gross fair values in the Consolidated Balance Sheets. The 
Company classifies cash flows related to derivative instruments as operating activities in the Consolidated Statements of Cash 
Flows.